HCA Healthcare, Inc. $HCA Stock Holdings Raised by Decker Wealth Management LLC

Decker Wealth Management LLC grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 13.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 17,460 shares of the company’s stock after buying an additional 2,102 shares during the period. HCA Healthcare makes up 1.5% of Decker Wealth Management LLC’s portfolio, making the stock its 23rd largest holding. Decker Wealth Management LLC’s holdings in HCA Healthcare were worth $7,451,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in HCA Healthcare during the second quarter valued at approximately $5,069,974,000. Legal & General Group Plc bought a new position in shares of HCA Healthcare during the 2nd quarter valued at approximately $410,992,000. Jupiter Topco LLC purchased a new position in HCA Healthcare during the second quarter worth $371,138,000. Wellington Management Group LLP raised its stake in shares of HCA Healthcare by 20.5% in the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after acquiring an additional 799,761 shares during the period. Finally, Bank of America Corp DE purchased a new position in shares of HCA Healthcare during the 2nd quarter worth about $238,457,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 1.3%

Shares of HCA Healthcare stock traded up $5.71 during trading on Friday, hitting $450.72. 980,841 shares of the stock traded hands, compared to its average volume of 1,344,523. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The stock’s fifty day simple moving average is $419.88 and its 200 day simple moving average is $419.76. The firm has a market cap of $97.58 billion, a P/E ratio of 15.09, a price-to-earnings-growth ratio of 1.48 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter last year, the firm posted $6.84 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. As a group, equities analysts expect that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th were given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on HCA. Robert W. Baird decreased their price objective on shares of HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating for the company in a research note on Monday, July 27th. Raymond James Financial set a $528.00 price target on HCA Healthcare in a research note on Tuesday, July 7th. Morgan Stanley decreased their target price on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research report on Monday, July 27th. Wells Fargo & Company upped their price target on shares of HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a report on Monday, August 3rd. Finally, JPMorgan Chase & Co. decreased their price objective on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a report on Thursday, August 20th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $466.35.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women’s and children’s care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.